Medication info
Olmedica HCT Tablet 5/20/12.5 mg

Olmedica HCT Tablet 5/20/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›20mg / 1 tabletAmlodipine Besylate›6.944mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Daewoo Pharmaceutical Co., Ltd.
Appearance
White-orange round film-coated tablet
Packaging
30 tablets (10 tablets/Alu-Alu × 3)
Approval status
Active

MFDS item code 201903062 · Approved 2019.05.10 · Insurance code 649605020

Summary

Main use
Treatment of essential hypertension not controlled with concomitant amlodipine and olmesartan
Who takes it
Adults · Children
Adult dose
Take 1 tablet once daily with water, with or without food. It is recommended to take it at the same time each day (e.g., in the morning), if possible. Before administering this drug, it is recommended that the dose of the individual ingredients (amlodipine and olmesartan medoxomil as monotherapy or combination therapy) be adjusted. However, if blood pressure is not controlled with combination therapy of amlodipine and olmesartan medoxomil, switching directly to this drug may be considered as follows. The maximum dose of this drug is 10/40/25mg of amlodipine/olmesartan medoxomil/hydrochlorothiazide. Since the maximum blood pressure-lowering effect occurs within 2 weeks of administration, adjust the dose at intervals of 2 weeks or longer, taking the patient's blood pressure response into account. The recommended doses are as follows. - 5/20/12.5mg: Administer to patients whose blood pressure is not adequately controlled with combination therapy of amlodipine/olmesartan medoxomil 5/20mg. - 5/40/12.5mg: Administer to patients whose blood pressure is not adequately controlled with combination therapy of amlodipine/olmesartan medoxomil 5/40mg or with this drug 5/20/12.5mg. - 5/40/25mg: Administer to patients whose blood pressure is not adequately controlled with this drug 5/40/12.5mg. - 10/40/12.5mg: Administer to patients whose blood pressure is not adequately controlled with combination therapy of amlodipine/olmesartan medoxomil 10/40mg or with this drug 5/40/12.5mg. - 10/40/25mg: Administer to patients whose blood pressure is not adequately controlled with this drug 5/40/25mg or this drug 10/40/12.5mg. ※ Refer to the following dose titration schedule. (The content of each ingredient is listed in the order amlodipine/olmesartan medoxomil/hydrochlorothiazide.) 5/20/0mg → 5/20/12.5mg ↓ 5/40/0mg → 5/40/12.5mg → 5/40/25mg ↓ ↓ 10/40/0mg → 10/40/12.5mg → 10/40/25mg Patients with renal impairment The maximum dose of this drug for patients with mild to moderate renal impairment (creatinine clearance 30-60mL/min) is 20/5/12.5 milligrams once daily. Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. Do not administer this drug to patients with severe renal impairment (creatinine clearance < 30mL/min). Patients with hepatic impairment Use caution when administering to patients with mild to moderate hepatic impairment. The maximum dose of this drug for patients with moderate hepatic impairment is 5/20/12.5 milligrams once daily. Blood pressure and renal function should be closely monitored in patients with hepatic impairment. Do not administer this drug to patients with severe hepatic impairment. Elderly patients (65 years and older) In general, initiate treatment at a low dose. When adjusting the dose, consider the patient's renal or cardiac function and comorbidities. Blood pressure should be monitored closely and more frequently in elderly patients. Use very close monitoring when administering this drug, particularly in patients 75 years and older, because experience with its use in this age group is very limited.
Child dose
Administration of this drug is not recommended in pediatric patients under 18 years because safety and efficacy have not been established.

Ingredients

Manufacturer
Daewoo Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with concomitant amlodipine and olmesartan

  • Essential hypertension
View approved original text

This medication is indicated for patients with essential hypertension who have difficulty controlling their blood pressure with the combination therapy of Amlodipine and Olmesartan Medoxomil. It helps lower blood pressure and relax blood vessels to manage hypertension. The combination of these two medications complements each other's actions, allowing for more effective blood pressure management. In particular, when blood pressure control is challenging with a single medication, the combination product can be beneficial. It is used for treating essential hypertension, and consistent use can significantly help in controlling blood pressure and preventing cardiovascular diseases.

How to take

Adult dose

Take 1 tablet once daily with water, with or without food. It is recommended to take it at the same time each day (e.g., in the morning), if possible. Before administering this drug, it is recommended that the dose of the individual ingredients (amlodipine and olmesartan medoxomil as monotherapy or combination therapy) be adjusted. However, if blood pressure is not controlled with combination therapy of amlodipine and olmesartan medoxomil, switching directly to this drug may be considered as follows. The maximum dose of this drug is 10/40/25mg of amlodipine/olmesartan medoxomil/hydrochlorothiazide. Since the maximum blood pressure-lowering effect occurs within 2 weeks of administration, adjust the dose at intervals of 2 weeks or longer, taking the patient's blood pressure response into account. The recommended doses are as follows. - 5/20/12.5mg: Administer to patients whose blood pressure is not adequately controlled with combination therapy of amlodipine/olmesartan medoxomil 5/20mg. - 5/40/12.5mg: Administer to patients whose blood pressure is not adequately controlled with combination therapy of amlodipine/olmesartan medoxomil 5/40mg or with this drug 5/20/12.5mg. - 5/40/25mg: Administer to patients whose blood pressure is not adequately controlled with this drug 5/40/12.5mg. - 10/40/12.5mg: Administer to patients whose blood pressure is not adequately controlled with combination therapy of amlodipine/olmesartan medoxomil 10/40mg or with this drug 5/40/12.5mg. - 10/40/25mg: Administer to patients whose blood pressure is not adequately controlled with this drug 5/40/25mg or this drug 10/40/12.5mg. ※ Refer to the following dose titration schedule. (The content of each ingredient is listed in the order amlodipine/olmesartan medoxomil/hydrochlorothiazide.) 5/20/0mg → 5/20/12.5mg ↓ 5/40/0mg → 5/40/12.5mg → 5/40/25mg ↓ ↓ 10/40/0mg → 10/40/12.5mg → 10/40/25mg Patients with renal impairment The maximum dose of this drug for patients with mild to moderate renal impairment (creatinine clearance 30-60mL/min) is 20/5/12.5 milligrams once daily. Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. Do not administer this drug to patients with severe renal impairment (creatinine clearance < 30mL/min). Patients with hepatic impairment Use caution when administering to patients with mild to moderate hepatic impairment. The maximum dose of this drug for patients with moderate hepatic impairment is 5/20/12.5 milligrams once daily. Blood pressure and renal function should be closely monitored in patients with hepatic impairment. Do not administer this drug to patients with severe hepatic impairment. Elderly patients (65 years and older) In general, initiate treatment at a low dose. When adjusting the dose, consider the patient's renal or cardiac function and comorbidities. Blood pressure should be monitored closely and more frequently in elderly patients. Use very close monitoring when administering this drug, particularly in patients 75 years and older, because experience with its use in this age group is very limited.

Child dose

Administration of this drug is not recommended in pediatric patients under 18 years because safety and efficacy have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn, especially during the second and third trimesters of pregnancy, so if pregnancy is confirmed, use should be discontinued immediately. Patients with allergies to any of the ingredients or similar medications, as well as those with certain heart, kidney, or liver diseases, and women who are pregnant or nursing should not take this medication. Patients with excessively low blood pressure, acute heart issues, or severe kidney or liver dysfunction should also avoid this medication. Caution is necessary during early treatment in patients with low blood volume or insufficient salt in the body, as blood pressure may drop sharply; appropriate treatment should be sought if symptoms arise. Patients with severe heart failure or impaired kidney function may experience worsening kidney function while taking this medication, thus regular monitoring is required. Patients with poor liver function or advanced liver cirrhosis, as well as those with specific heart valve disorders, should use this medication with caution. Since this medication has a strong blood pressure-lowering effect, caution is needed when taking it with other antihypertensive drugs, alcohol, or sedatives, as it may cause hypotension or dizziness. While taking this medication, there may be occurrences of dehydration or electrolyte imbalance (e.g., changes in potassium, sodium, magnesium levels), so regular blood tests are necessary. The skin may become sensitive to sunlight; thus, using sunscreen and avoiding direct sunlight is recommended when going outside. This medication can also be used in the elderly, but dosage adjustments and caution are necessary if kidney or liver function is impaired. In cases of overdose, blood pressure may drop too low; individuals should seek immediate medical attention for appropriate treatment. This medication is not recommended for children and adolescents under the age of 18, as safety and effectiveness have not been sufficiently established. This medication should be stored in a tightly sealed container to protect it from air and moisture, and out of the reach of children.

Side effects

Peripheral edema, headache, dizziness, upper respiratory tract infection, nasopharyngitis, urinary tract infection, sialadenitis, leukopenia, thrombocytopenia, bone marrow suppression, neutropenia, agranulocytosis, hemolytic anemia, aplastic anemia, anaphylactic reaction, drug hypersensitivity, hyperkalemia, hypokalemia, anorexia, diabetes, hypercalcemia, hyperglycemia, hypomagnesemia, hyponatremia, hypochloremia, hypertriglyceridemia, hypercholesterolemia, hyperuricemia, hypochloremic alkalosis, hyperamylasemia, confusion, depression, apathy, hypersensitivity, anxiety, mood changes, sleep disturbances, neurological abnormalities, orthostatic dizziness, syncope, taste disorder, hypertonia, sensory impairment, paresthesia, peripheral neuropathy, drowsiness, fainting, seizures, loss of appetite, tremor, vision changes, reduced tear production, worsening of myopia, jaundice, vertigo, tinnitus, palpitations, tachycardia, myocardial infarction, arrhythmia, angina, hypotension, flushing, orthostatic hypotension, vasculitis, thrombosis, embolism, cough, bronchitis, dyspnea, pharyngitis, rhinitis, acute interstitial pneumonia, respiratory distress syndrome, pulmonary edema, diarrhea, nausea, constipation, dry mouth, abdominal pain, changes in bowel habits, bloating, dyspepsia, gastritis, gastric discomfort, gastroenteritis, gingival hyperplasia, paralytic ileus, pancreatitis, vomiting, hepatitis, jaundice, acute cholecystitis, autoimmune hepatitis, hair loss, angioedema, allergic dermatitis, erythema multiforme, erythema, lupus erythematosus-like skin reaction, pustular rash, exfoliative dermatitis, hyperhidrosis, photosensitivity reaction, pruritus, purpura, Quincke's edema, rash, recurrence of lupus erythematosus, toxic skin necrosis, skin discoloration, Stevens-Johnson syndrome, urticaria, muscle spasm, joint edema, muscle weakness, ankle edema, arthralgia, arthritis, low back pain, paresis, myalgia, bone pain, increased urination, acute renal failure, hematuria, voiding dysfunction, nocturia, interstitial nephritis, renal failure, erectile dysfunction, gynecomastia, asthenia, fatigue, chest pain, fever, influenza-like symptoms, lethargy, malaise, edema, pain, facial edema, elevated serum creatinine, elevated serum urea, elevated serum uric acid, decreased serum potassium, elevated gamma-glutamyl transferase, elevated alanine aminotransferase, elevated aspartate aminotransferase, elevated liver enzymes, elevated serum creatinine phosphokinase, weight loss, weight gain, rhabdomyolysis, chronic malabsorption syndrome, intestinal vascular edema, altered consciousness, drug hypersensitivity, upper abdominal pain, decreased libido, labial edema, asthenia, eczema, limb pain, mild decrease in average hemoglobin and hematocrit levels, dizziness, benign prostatic hyperplasia, benign salivary gland neoplasms, cerebral infarction, renal failure, abdominal distension, facial flushing, epistaxis, benign prostatic enlargement, prostatitis, dysphagia, papular rash, renal cell dysplasia, acute hearing loss, lymphadenitis, acute respiratory distress syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to protect it from air and moisture. It is advisable to keep it at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

White-orange round film-coated tablet

Package unit

30 tablets (10 tablets/Alu-Alu × 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.